Dr. Joseph Anthony Pipesh, D.D.S. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 730 Durkee St, Nashville, MI 49073 Phone: 517-852-9150 |
News Archive
An analysis of data from previously published studies indicates that intensive-dose statin therapy is associated with an increased risk of new-onset diabetes compared with moderate-dose therapy, according to a study in the June 22/29 issue of JAMA.
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced Phase 3 study results for linagliptin 5 mg once-daily, which showed significant hemoglobin A1c (HbA1c or A1C) reduction of 0.88 percent compared to 0.24 percent in the placebo group (p=0.0002) at 24 weeks in black or African American adult patients with type 2 diabetes whose blood sugar was not adequately controlled.
With tightening transparency requirements the pharmaceutical industry is under increasing pressure to ensure fully compliant communication and interactions through all areas of their business functions. How can you evolve current business practices to build a real cross functional, promotional compliance organisation?
An international team led by researchers from the Universities of Leicester and Cambridge has announced a breakthrough in identifying people at risk of developing potentially fatal blood clots that can lead to heart attack.
Avita Medical Ltd., the regenerative medicine company, today announced that the United States Food and Drug Administration (FDA) has approved the Company's investigational device exemption (IDE) feasibility study for the use of ReCell Spray-On-Skin in the treatment of hypertrophic dyspigmented scars: i.e., raised and/or discoloured scars.
› Verified 9 days ago